Lead Exposure and Prevention Advisory Committee (LEPAC); Meeting

• Published date: 27 March 2020
• Citation: 85 FR 17334
• Record Number: 2020-06367
• Section: Notices
• Court: Centers For Disease Control And Prevention,Health And Human Services Department

Federal Register, Volume 85 Issue 60 (Friday, March 27, 2020)

[Federal Register Volume 85, Number 60 (Friday, March 27, 2020)]
                [Notices]
                [Page 17334]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2020-06367]
                =======================================================================
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                Centers for Disease Control and Prevention
                Lead Exposure and Prevention Advisory Committee (LEPAC); Meeting
                AGENCY: Centers for Disease Control and Prevention (CDC), Department of
                Health and Human Services (HHS).
                ACTION: Notice of meeting.
                -----------------------------------------------------------------------
                SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
                announces the following meeting for the Lead Exposure and Prevention
                Advisory Committee (LEPAC). This meeting is open to the public by web
                conference; however, advance registration is needed by April 15, 2020,
                to receive the information to join the meeting. The registration link
                is https://rossstrategic.zoom.us/webinar/register/WN_I76JZ04RT5SVinnqu_tSYw. The public comment period is scheduled on
                April 29, 2020, from 1:45 p.m. until 2:00 p.m., EDT. Individuals
                wishing to make a comment during the public comment period, please
                email your name, organization, and phone number by April 15, 2020, to
                [email protected].
                DATES: The meeting will be held on April 29, 2020, from 9:00 a.m. to
                4:30 p.m., EDT.
                ADDRESSES: To receive web conference access please register at https://rossstrategic.zoom.us/webinar/register/WN_I76JZ04RT5SVinnqu_tSYw by
                April 15, 2020.
                FOR FURTHER INFORMATION CONTACT: Ms. Perri Ruckart, M.P.H., Designated
                Federal Officer, National Center for Environmental Health, CDC, 4770
                Buford Highway, Atlanta, GA 30341, 770-488-3300; email address:
                [email protected].
                SUPPLEMENTARY INFORMATION:
                 Purpose: The Lead Exposure and Prevention Advisory Committee was
                established under Section 2203 of Public Law 114-322, the Water
                Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-27,
                Registry for Lead Exposure and Advisory Committee.
                 The Secretary, Department of Health and Human Services (HHS) and by
                delegation, the Director, CDC and Administrator, NCEH/ATSDR, are
                authorized under Section 2203 of Public Law 114-322 (42 U.S.C. 300j-27)
                to review research and Federal programs and services related to lead
                poisoning and to identify effective services and best practices for
                addressing and preventing lead exposure in communities.
                 The LEPAC is charged with providing advice and guidance to the
                Secretary, HHS, and the Director, CDC and Administrator, ATSDR, on the:
                (1) Review of Federal programs and services available to individual
                communities exposed to lead; (2) review current research on lead
                exposure to identify additional research needs; (3) review and identify
                best practices, or the need for best practices regarding lead screening
                and the prevention of lead poisoning; (4) identify effective services,
                including services relating to healthcare, education, and nutrition for
                individuals and communities affected by lead exposure and lead
                poisoning, including in consultation with, as appropriate, the lead
                exposure registry as established in Section 2203(b) of Public Law 114-
                322; and (5) undertake any other review or activities that the
                Secretary determines to be appropriate.
                 Matters To Be Considered: The agenda will include: Discussions on
                CDC's role in lead poisoning prevention, key federal lead programs and
                the Federal Lead Action Plan, methods and results of a Community Guide
                environmental scan and scoping review of lead interventions, lessons
                learned from review of CDC Childhood Lead Poisoning Prevention Program
                (CLPPP) cooperative agreement recipients, and available services and
                best practices regarding lead screening and the prevention of lead
                poisoning. Agenda items are subject to change as priorities dictate.
                 The Director, Strategic Business Initiatives Unit, Office of the
                Chief Operating Officer, Centers for Disease Control and Prevention,
                has been delegated the authority to sign Federal Register notices
                pertaining to announcements of meetings and other committee management
                activities, for both the Centers for Disease Control and Prevention and
                the Agency for Toxic Substances and Disease Registry.
                Kalwant Smagh,
                Director, Strategic Business Initiatives Unit, Office of the Chief
                Operating Officer, Centers for Disease Control and Prevention.
                [FR Doc. 2020-06367 Filed 3-26-20; 8:45 am]
                 BILLING CODE 4163-18-P